Abstract:Background The role of B cells in anti-tumor immunity remains controversial, with studies suggesting the pro-tumor and anti-tumor activity. This controversy may be due to the heterogeneity in B cell populations, as the balance among the subtypes may impact tumor progression. The immunosuppressive regulatory B cells (Breg) release IL-10 but only represent a minor population. Additionally, tumor-specific antibodies (Ab) also exhibit anti-tumor and pro-tumor function dependent on the Ab isotype. Transcription factor c-Maf has been suggested to contribute to the regulation of IL-10 in Breg, but the role of B cell c-Maf signaling in anti-tumor immunity and regulating antibody responses remain unknown. Methods Conditional B cell c-Maf knockout (KO) and control mice were used to establish a KPC pancreatic cancer model and B16.F10 melanoma model. Tumor progression was evaluated. B cell and T cell phenotypes were determined by flow cytometry, mass cytometry, and cytokine/chemokine profiling. Differentially expressed genes in B cells were examined by using RNA-seq. Peripheral blood samples were collected from healthy donors and melanoma patients for B cell phenotyping. Results Compared to B cells from spleen and lymph nodes, B cells in the pancreas exhibited significantly less follicular phenotype and higher IL-10 production in tumor-free mice. c-Maf deficiency resulted in a significant reduction of CD9+ IL-10-producing Breg in the pancreas. PDAC progression resulted in accumulation of circulating B cells with follicular phenotype and less IL-10 production in the pancreas. Notably, B cell c-Maf deficiency delayed PDAC tumor progression and resulted in pro-inflammatory B cells. Further, tumor volume reduction and increased effective T cells in the tumor-draining lymph node (TDLN) were observed in B cell c-Maf KO mice in the B16.F10 melanoma model. RNA-seq analysis of isolated B cells revealed that B cell c-Maf signaling modulates immunoglobulin (Ig)-associated genes and tumor specific antibody production. We furthermore demonstrated c-Maf-positive B cell subsets and increase of IL-10-producing B cells after incubation with IL-4 and CD40L in the peripheral blood of melanoma patients. Conclusion Our study highlights that B cell c-Maf signaling drives tumor progression through the modulation of Breg, inflammatory responses, and tumor-specific Ab responses.

B10 cells: Development, phenotype, and function in cancer

[Research Progress in B10 Cells and Autoimmune Diseases].

Purification and immunophenotypic characterization of murine B10 B cells.

B cell regulation of the anti-tumor response and role in carcinogenesis

B cell regulation in cancer and anti-tumor immunity

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells

Il-10-Independent Regulatory B-Cell Subsets and Mechanisms of Action

Regulatory B cells and T cell Regulation in Cancer

Progress of regulatory B cell's immunosuppression against tumor immunity

The Roles of Regulatory B Cells in Cancer

The Identification, Development and Therapeutic Potential of IL-10-producing Regulatory B Cells in Multiple Sclerosis

A strategy of targeting B10 cell by CD19scFv-IL10R for tumor therapy

Regulatory B1a Cells Suppress Melanoma Tumor Immunity via IL-10 Production and Inhibiting T Helper Type 1 Cytokine Production in Tumor-Infiltrating CD8+ T Cells

Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma

B cell c-Maf signaling promotes tumor progression in animal models of pancreatic cancer and melanoma

Il-10 Enhances Ctl-Mediated Tumor Rejection By Inhibiting Highly Suppressive Cd4(+) T Cells And Promoting Ctl Persistence In A Murine Model Of Plasmacytoma

Mechanisms of induction of regulatory B cells in the tumour microenvironment and their contribution to immunosuppression and pro-tumour responses

Regulatory B cells:research advances

Positive and negative functions of B lymphocytes in tumors

Interleukin-10 overexpression in 4T1 cells: A gateway to suppressing mammary carcinoma growth

Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer